Participants sought for hearing loss drug trial People with hearing loss are being invited to join a clinical trial of a new drug call ed REGAIN. Age-related hearing loss is usually caused by loss of inner ear sensory cells. The assumption has long been that this type of hearing loss (“sensorineural hearing loss”) is irreversible because once the hair cells in the […]
Autifony starts pilot study Autifony has began a pilot study to evaluate its new compound AUT00063 (called QuicK+fire) in adult cochlear implant (CI) users. The study, which is being conducted in the UK, is aimed at improving the hearing of adult CI users, particularly in challenging environments such as with background noise. It is thought that AUT00063 will help enhance people’s hearing […]
